157 results on '"Garcia, Ruel T"'
Search Results
2. Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients
3. Safety and efficacy of entecavir in adefovir-experienced patients
4. Less-Established Risk Factors Are Common in Asian Americans with Hepatitis C Virus: A Case–Controlled Study
5. Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study
6. Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B
7. Management of Common Bile Duct Stones in Cirrhotic Patients with Coagulopathy: A Comparison of Supra-Papillary Puncture and Standard Cannulation Technique
8. Significant Prevalence of Histologic Disease in Patients With Chronic Hepatitis B and Mildly Elevated Serum Alanine Aminotransferase Levels
9. Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans
10. Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting
11. Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B
12. Prevalence of Colorectal Neoplasms in Asian Americans
13. Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice
14. Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection
15. Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6
16. Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels
17. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil#
18. Low Proportion of Barrettʼs Esophagus in Asian Americans
19. Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis
20. Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: a multicenter randomized trial
21. Racial differences in effectiveness of α-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis
22. High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver-related Complaints.
23. Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C.
24. Mo1896 Chronic Hepatitis B (CHB) Treatment Eligibility and Actual Treatment Rates at Community Gastroenterology Clinics and Primary Care Clinics
25. Mo1893 Evaluation of Treatment-Eligibility for Antiviral Therapy During Follow-up in Chronic Hepatitis B Patients Initially Ineligible for Treatment
26. Su2044 Incidence of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients With Chronic Hepatitis B (CHB): Results of a Multicenter Cohort Study
27. Sa1087 Less Established Risk Factors are Common in Asian Americans With Hepatitis C Virus: A Case-Control Study
28. Sa1043 Outcomes of Oral Antiviral Treatment for Chronic Hepatitis B (CHB) in Routine Clinical Practice
29. Sa1003 High Prevalence of Hepatitis C Virus in Ethnically Diverse Community Patients With Non-Liver Related Gastrointestinal Complaints
30. HBV Precore C1858T Mutation Does Not Share Similar Clinical or Virologic Characteristics With Other Precore Mutants
31. Hepatitis B Virus (HBV) Reverse Transcriptase Mutation Prevalence Was Low in Treatment-NaïVE Patients With Chronic Hepatitis B (CHB) Using Inno-Lipa HBV DR3 in a Prospective Multicenter Study
32. Rapid Complete Viral Suppression (CVS) With Entecavir (ETV) in Adefovir (ADV)-Experienced Patients: Interim Report for a Multicenter Study
33. Long-Term Treatment Response to Entecavir and Adefovir in Treatment-NaïVE Chronic Hepatitis B E Antigen-Negative Patients in a Community Setting
34. Treatment of Chronic Hepatitis B Patients According to Current Guidelines: A Community-Based Study
35. Incidence and Predictors of Hepatitis B E Antigen (HBeAg) Seroconversion in Chronic Hepatitis B (CHB) Patients Treated With Anti-HBV Therapy in Routine Clinical Practice
36. Annual Incidence for Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Patients With Chronic Hepatitis B (CHB) and Cirrhotic Patients of All Etiologies
37. High Rate of Recurrent Hepatitis B Viremia Following Treatment-Induced Hepatitis B E Antigen (HBeAg) Seroconversion
38. Proportion of Patients Who Were Previously Ineligible for Anti-HBV Therapy Who Became Eligible After 12 Months of Follow-up: Application of U.S. Panel and AASLD Guidelines
39. EUS-guided FNA for GI stromal tumors: caveat lector
40. T1967 Asian Ethnicity is a Significant Predictor for Viral Dominance by HBV in HBV/HCV Co-Infected Patients: A Multicenter, Matched Case-Control Study
41. M1903 Long-Term Outcome of Treatment-NaïVE Chronic Hepatitis B (CHB) E Antigen-Negative Treated With Entecavir 0.5 Mg (ETV) or Adefovir 10 Mg (ADV) in a Real-Life Community Setting
42. M1893 Hepatitis B Virus Reverse Transcriptase Mutations Were Not Detected in Treatment-NaïVE Patients With Chronic Hepatitis B Using Inno Lipa HBV DR3: A Prospective Multicenter Study
43. M1892 Hepatitis B-E Antigen Positive (HBeAg+) Chronic Hepatitis B (CHB) Patients With Precore (PC) and Basic Core Promoter (BCP) Mutations
44. 636 High Rate of Complete Viral Suppression With Combination Therapy With Tenofovir Using Entecavir or Lamivudine/Emtricitabine in Patients With Chronic Hepatitis B and Prior Monotherapy Failure
45. 634 Treatment Efficacy of Entecavir (ETV) Therapy in Patients Previously Treated With Adefovir (ADV): Interim Report for a Multicenter Study
46. 314 Randomized Controlled Trial of Pegylated Interferon-Alpha 2a and Ribavirin in Patients With Treatment-NaïVE Chronic Hepatitis C Genotype 6
47. 80 Hepatocellular Carcinoma Incidence in a Cohort of 981 U.S. Patients With Chronic Hepatitis B Without Cirrhosis and Patients With Cirrhosis of All Etiologies
48. W1813 Incidences of Renal Dysfunction in Chronic Hepatitis B (CHB) Patients Treated with Adefovir Dipivoxil (ADV) 10mg
49. W1810 Long-Term Outcome At Year 5 in Chronic Hepatitis B (CHB) Patients Initially Treated with Adefovir Dipivoxil (ADV) in a Real-Life Clinical Setting
50. W1809 Changes in Creatinine Clearance (CrCl) in Chronic Hepatitis B (CHB) Patients Treated with Adefovir Dipivoxil (ADV): A Case-Control Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.